A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells
2013 · Cancer Research · 169 citations
https://doi.org/10.1158/0008-5472.can-12-4501
T
Timothy P. Cripe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
359
Papers
8.2K
Citations
55
h-index
125
i10-index
Timothy P. Cripe is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Virus-based gene therapy research & CAR-T cell therapy research & Neuroblastoma Research and Treatments. The author has an h-index of 55, co-authored 306 publications.
ORCID: 0000-0002-8595-3577Papers by this author
worksFirst-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
2019 · Molecular Therapy · 59 citations
https://doi.org/10.1016/j.ymthe.2019.08.020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival
2019 · Molecular Therapy — Oncolytics · 52 citations
https://doi.org/10.1016/j.omto.2019.10.005
Oncolytic virotherapy reaches adolescence
2010 · Pediatric Blood & Cancer · 45 citations
https://doi.org/10.1002/pbc.22724
Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors
2017 · Molecular Therapy — Oncolytics · 44 citations
https://doi.org/10.1016/j.omto.2017.05.005
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
2014 · Molecular Therapy — Oncolytics · 43 citations
https://doi.org/10.1038/mto.2014.10
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat